Eli Lilly and Regeneron are among the first seven companies the FDA has selected for its PreCheck Pilot Program, CNBC has ...

Regeneron Pharmaceuticals has announced a new manufacturing and supply agreement with FUJIFILM Diosynth Biotechnologies to enhance its production capacity for biologic medicines at Fujifilm's facility ...

June 29 (Reuters) - The U.S. Food and Drug Administration has selected Eli Lilly, Regeneron and five other companies for a ...

New manufacturing and supply agreement with FUJIFILM Diosynth Biotechnologies in North Carolina will enable additional production of Regeneron’s biologic medicines and support high-paying jobs in the ...

FUJIFILM Diosynth Biotechnologies, a world-leading contract development and manufacturing organization (CDMO) for biologics, vaccines, and advanced therapies, today announced a 10-year manufacturing ...

The FDA estimates the PreCheck program could save participating companies up to 14 months by reviewing facilities while they are still under construction ...

Biopharma giants Eli Lilly and Regeneron and rapidly growing contract manufacturers Fujifilm and Cellares, are among the seven companies selected by the FDA for its PreCheck Pilot Program, an ...

FUJIFILM Diosynth Biotechnologies signed a 10-year manufacturing supply agreement, valued at over $3 billion, with Regeneron Pharmaceuticals to provide U.S.-based production of its biologic medicines.

June 29 (Reuters) - The U.S. Food and Drug Administration on Monday selected Eli Lilly (LLY.N), opens new tab, Regeneron (REGN.O), opens new tab and five other companies for a pilot program to ...

Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: Eli Lilly and Company’s logo is displayed during a press conference in Houston, Texas, U.S., September 23, 2025.